Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott Medical Devices
The objective of this study is to evaluate whether percutaneous PFO closure is effective in reducing the incidence of disabling migraine headaches in patients who are refactory to medical treatment.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects diagnosed as having migraine headaches both with and without aura
Have a Patent Foramen Ovale (PFO)
A migraine history and show a refractoriness to medical treatment
Willing to participate in follow-up visits
You may not be if
Subjects whose primary headaches are other than migraine headaches
Who overuse migraine treatments
With a clinical history of stroke or Transient Ischemic Attack (TIA)
With contraindication to aspirin therapy and Clopidogrel
Pregnant or desire to become pregnant within the next year
